June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

June 17, 2025

FMT as First-Line CDI Treatment?

New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections

Conexiant

June 17, 2025

Aconitine Tames Joints, Protects Bone

At EULAR 2025, researchers presented data showing aconitine reduced bone erosion and increased regulatory T cells in a rheumatoid arthritis mouse model.

Conexiant

June 13, 2025

Riva Returns!

Luigi Mondello explains why the time is right to reignite Chromatography’s much-missed “scientific retreat”

The Analytical Scientist

June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 05, 2025

Conservative Mental Health Study Faces Retraction

Scandinavian Journal of Psychology retracts study on conservatism and mental health, citing methodological flaws and biased language despite authors' objections.

Conexiant

June 04, 2025

Dog Exposure May Lower Genetic Eczema Risk

A large European study found that early-life dog exposure may reduce the genetic risk for atopic eczema, with lab results confirming a biological mechanism involving immune signaling in skin cells.

Conexiant

June 02, 2025

Gut Microbiome Changes Observed in ITP Patients

A new review of 12 studies found gut microbiome changes in patients with immune thrombocytopenia, though results were inconsistent across populations and methods.

Conexiant

June 02, 2025

Glycosylated IgG Disrupts Kidney Cell Metabolism: Study 

Children with lupus nephritis had altered IgG sugar chains that impaired kidney cell metabolism, and removing those sugars reversed the injury in lab tests.

Conexiant